 | Up a level |
2022
Heesen, C., Mokry, C., Salmen, A., Hegen, H., Maurer, M., Warnke, C., Gehring, K., Berthele, A. and Meier, U. (2022). German guideline for diagnosis and treatment of multiple sclerosis-a survey focusing neurologists in daily practise. Mult. Scler. Relat. Disord., 63. OXFORD: ELSEVIER SCI LTD. ISSN 2211-0356
Mokry, C., Warnke, C., Gehring, K., Hegen, H., Salmen, A., Kraemer, M., Kleiter, I, Fasshauer, E., Scheiderbauer, J., Luehmann, D., Koepke, S., Berthele, A. and Heesen, C. (2022). Implementation study of the 2021 German guideline for diagnosis and treatment of multiple sclerosis. Mult. Scler. Relat. Disord., 57. OXFORD: ELSEVIER SCI LTD. ISSN 2211-0356
Schneider, A., Fasshauer, E., Scheiderbauer, J., Warnke, C., Koepke, S., Kasper, J., Toussaint, M., Temmes, H., Hemmer, B., Schiffmann, I, Rahn, A. C. and Heesen, C. (2022). Development and evaluation of evidence-based patient information handbooks about multiple sclerosis immunotherapies. Mult. Scler. Relat. Disord., 60. OXFORD: ELSEVIER SCI LTD. ISSN 2211-0356
2021
Garcia Borrega, J., Heindel, K., Kochanek, M., Warnke, C., Stemmler, J., von Bergwelt-Baildon, M., Liebregts, T. and Boell, B. (2021). The critically ill CAR T-cell patient Relevant toxicities, their management and challenges in critical care. Med. Klin.-Intensivmed Notfallmed., 116 (2). S. 121 - 129. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 2193-6226
2020
Goereci, Y., Schweitzer, F., Wellstein, A., Silling, S., Borchmann, S., von Tresckow, B., Adams, O., Martin, R., Schlamann, M., Schroeter, M., Fink, G. R., Wattjes, M. P. and Warnke, C. (2020). Clearance of JC polyomavirus from cerebrospinal fluid following treatment with interleukin-2 and pembrolizumab in an individual with progressive multifocal leukoencephalopathy and no underlying immune deficiency syndrome. Eur. J. Neurol., 27 (11). S. 2375 - 2378. HOBOKEN: WILEY. ISSN 1468-1331
Ladwig, A., Suh, J., Schweitzer, F., Roeth, P., Remke, G., Warnke, C., Schroeter, M., Izquierdo-Alvarez, E., Bonmann, E., Fink, G. R., Pallasch, C. and Lehmann, H. (2020). Alemtuzumab induces changes in the innate immune system in patients with relapsing-remitting multiple sclerosis. Mult. Scler. J., 26 (3_SUPPL). S. 259 - 260. LONDON: SAGE PUBLICATIONS LTD. ISSN 1477-0970
Schweitzer, F., Ladwig, A., Laurent, S., Schroeter, M., Goelz, S., Wieland, U., Silling, S. and Warnke, C. (2020). Is the gut a relevant reservoir for persistent jcpyv infection? Mult. Scler. J., 26 (3_SUPPL). S. 286 - 288. LONDON: SAGE PUBLICATIONS LTD. ISSN 1477-0970
2018
Abrahamyan, S., Eberspaecher, B., Ambrosius, B., Hessler, N., Antony, G., Koenig, I. R., Hoshi, M. -M., Aly, L., Luessi, F., Groppa, S., Klotz, L., Meuth, S. G., Tackenberg, B., Stoppe, M., Bergh, F. Then, Tumani, H., Kuempfel, T., Stangel, M., Heesen, C., Wildemann, B., Paul, F., Bayas, A., Warnke, C., Weber, F., Linker, R. A., Ziemann, U., Zettl, U. K., Zipp, F., Wiendl, H., Hemmer, B., Gold, R., Salmen, A. and Ruprecht, K. (2018). Absence of Epstein-Barr virus seronegativity in a large cohort of patients with early multiple sclerosis. Mult. Scler. J., 24. S. 981 - 983. LONDON: SAGE PUBLICATIONS LTD. ISSN 1477-0970
Ambrosius, B., Hessler, N., Antony, G., Konig, I. R., Hoshi, M-M., Aly, L., Luessi, F., Groppa, S., Klotz, L., Meuth, S. G., Tackenberg, B., Stoppe, M., Bergh, F. Then, Tumani, H., Kuempfel, T., Stangel, M., Heesen, C., Wildemann, B., Paul, F., Bayas, A., Warnke, C., Weber, F., Linker, R. A., Ziemann, U., Zettl, U. K., Zipp, F., Wiendl, H., Hemmer, B., Gold, R. and Salmen, A. (2018). Changes of disease characteristics and disease-modifying treatment within one year in the National German MS cohort. Mult. Scler. J., 24. S. 554 - 557. LONDON: SAGE PUBLICATIONS LTD. ISSN 1477-0970
Huss, A., Otto, M., Tackenberg, B., Stangel, M., Aktas, O., Meuth, S., Gross, C. C., Bayas, A., Wildemann, B., Luessi, F., Seipelt, M., Puetz, M., Antony, G., Weber, F., Uhr, M., Bischof', F., Ruprecht, K., Buck, D., Retzlaff, N., Zettl, U. K., Haghikia, A., Lukas, C., Hartung, H. -P., Bergh, F. Then, Warnke, C., Zipp, F., Wiendl, H., Hemmer, B., Gold, R. and Tumani, H. (2018). Prospective multicenter validation of CSF protein biomarkers in patients with CIS and early MS. Mult. Scler. J., 24. S. 656 - 658. LONDON: SAGE PUBLICATIONS LTD. ISSN 1477-0970
2017
Frenken, P., Hartung, H-P., Olsson, T., Adams, O. and Warnke, C. (2017). Type 0 blood group associates with higher anti-JCV antibody levels. Mult. Scler. J., 23. S. 918 - 920. LONDON: SAGE PUBLICATIONS LTD. ISSN 1477-0970